{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:52:44Z","timestamp":1790693564425,"version":"4.1.0"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":179,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1111\/ijcp.12639","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T07:05:09Z","timestamp":1425625509000},"page":"410-421","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?"],"prefix":"10.1155","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6098-9266","authenticated-orcid":false,"given":"L.","family":"Citrome","sequence":"first","affiliation":[{"name":"Department of Psychiatry & Behavioral Sciences; New York Medical College; Valhalla NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,3,6]]},"reference":[{"key":"10.1111\/ijcp.12639-BIB0001|ijcp12639-cit-0001","doi-asserted-by":"crossref","unstructured":"US Food and Drug Administration. Drug Approval Package Vyvanse (Lisdexamfetamine Dimesylate) Capsules http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2007\/021977s000TOC.cfm","DOI":"10.3833\/pdr.v2007i82.356"},{"key":"10.1111\/ijcp.12639-BIB0002|ijcp12639-cit-0002","unstructured":"US Food and Drug Administration FDA expands uses of Vyvanse to treat binge-eating disorder http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm432543.htm"},{"key":"10.1111\/ijcp.12639-BIB0003|ijcp12639-cit-0003","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.biopsych.2006.03.040","article-title":"The prevalence and correlates of eating disorder in the National Comorbidity Survey Replication","volume":"61","author":"Hudson","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1111\/ijcp.12639-BIB0004|ijcp12639-cit-0004","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.biopsych.2012.11.020","article-title":"The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys","volume":"73","author":"Kessler","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1111\/ijcp.12639-BIB0005|ijcp12639-cit-0005","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF01575455","article-title":"Eating patterns and obesity","volume":"33","author":"Stunkard","year":"1959","journal-title":"Psychiatr Q"},{"key":"10.1111\/ijcp.12639-BIB0006|ijcp12639-cit-0006","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","edition":"5"},{"key":"10.1111\/ijcp.12639-BIB0007|ijcp12639-cit-0007","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3810\/pgm.2014.09.2800","article-title":"The patient experience with DSM-5-defined binge eating disorder: characteristics, barriers to treatment, and implications for primary care physicians","volume":"126","author":"Herman","year":"2014","journal-title":"Postgrad Med"},{"key":"10.1111\/ijcp.12639-BIB0008|ijcp12639-cit-0008","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.psc.2011.08.011","article-title":"Treatment of binge eating disorder","volume":"34","author":"Wilson","year":"2011","journal-title":"Psychiatr Clin North Am"},{"key":"10.1111\/ijcp.12639-BIB0009|ijcp12639-cit-0009","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/eat.20696","article-title":"Meta-analysis of the effectiveness of psychological and pharmacological treatments for binge eating disorder","volume":"43","author":"Vocks","year":"2010","journal-title":"Int J Eat Disord"},{"key":"10.1111\/ijcp.12639-BIB0010|ijcp12639-cit-0010","unstructured":"Shire VYVANSE (lisdexamfetamine dimesylate) capsules, for oral use, CII http:\/\/pi.shirecontent.com\/PI\/PDFs\/Vyvanse_USA_ENG.pdf"},{"key":"10.1111\/ijcp.12639-BIB0011|ijcp12639-cit-0011","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2014.2162","article-title":"Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial","author":"McElroy","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1111\/ijcp.12639-BIB0012|ijcp12639-cit-0012","doi-asserted-by":"crossref","unstructured":"McElroy S Hudson J Ferreira-Cornwell MC Radewonuk J Gasior M Randomized controlled safety and efficacy trials of lisdexamfetamine dimesylate for adults with moderate to severe binge eating disorder New York, NY 2014","DOI":"10.1001\/jamapsychiatry.2014.2162"},{"key":"10.1111\/ijcp.12639-BIB0013|ijcp12639-cit-0013","unstructured":"Vickers SP Heal DJ Hackett D Hutson PH Effect of lisdexamfetamine in a rat model of binge-eating disorder San Diego CA 2013"},{"key":"10.1111\/ijcp.12639-BIB0014|ijcp12639-cit-0014","unstructured":"Hutson P Prow M Rowley H Cheetham S Heal D Lisdexamfetamine-induced suppression of binge eating in rats is attenuated by the alpha-1 adrenoceptor antagonist, Prazosin Phoenix, AZ 2014"},{"key":"10.1111\/ijcp.12639-BIB0015|ijcp12639-cit-0015","doi-asserted-by":"crossref","unstructured":"Heal D Vickers S Hackett D Hutson P Effect of lisdexamfetamine in a rat model of binge-eating disorder. Poster P.1.g.034 Barcelona, Spain 2013","DOI":"10.1016\/S0924-977X(13)70321-3"},{"key":"10.1111\/ijcp.12639-BIB0016|ijcp12639-cit-0016","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1600-0447.2008.01194.x","article-title":"Compelling or irrelevant? Using number needed to treat can help decide","volume":"117","author":"Citrome","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"10.1111\/ijcp.12639-BIB0017|ijcp12639-cit-0017","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/157488609789006985","article-title":"Quantifying risk: the role of absolute and relative measures in interpreting risk of adverse reactions from product labels of antipsychotic medications","volume":"4","author":"Citrome","year":"2009","journal-title":"Curr Drug Saf"},{"key":"10.1111\/ijcp.12639-BIB0018|ijcp12639-cit-0018","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ijcp.12142","article-title":"When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed","volume":"67","author":"Citrome","year":"2013","journal-title":"Int J Clin Pract"},{"key":"10.1111\/ijcp.12639-BIB0019|ijcp12639-cit-0019","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0269881113482532","article-title":"Amphetamine, past and present - a pharmacological and clinical perspective","volume":"27","author":"Heal","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1111\/ijcp.12639-BIB0020|ijcp12639-cit-0020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2165\/0044011-200828120-00002","article-title":"Metabolism, distribution and elimination of lisdexamfetamine dimesylate: open-label, single-centre, phase I study in healthy adult volunteers","volume":"28","author":"Krishnan","year":"2008","journal-title":"Clin Drug Investig"},{"key":"10.1111\/ijcp.12639-BIB0021|ijcp12639-cit-0021","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1177\/0091270009357346","article-title":"Lisdexamfetamine dimesylate: linear dose-proportionality, low intersubject and intrasubject variability, and safety in an open-label single-dose pharmacokinetic study in healthy adult volunteers","volume":"50","author":"Ermer","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/ijcp.12639-BIB0022|ijcp12639-cit-0022","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1185\/030079908X242737","article-title":"Multiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers","volume":"24","author":"Krishnan","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/ijcp.12639-BIB0023|ijcp12639-cit-0023","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0091270007310381","article-title":"Relative bioavailability of lisdexamfetamine 70-mg capsules in fasted and fed healthy adult volunteers and in solution: a single-dose, crossover pharmacokinetic study","volume":"48","author":"Krishnan","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/ijcp.12639-BIB0024|ijcp12639-cit-0024","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/0269881109103113","article-title":"Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse","volume":"23","author":"Jasinski","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1111\/ijcp.12639-BIB0025|ijcp12639-cit-0025","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1586\/14737175.8.7.1079","article-title":"Antipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks","volume":"8","author":"Citrome","year":"2008","journal-title":"J Expert Rev Neurother"},{"key":"10.1111\/ijcp.12639-BIB0026|ijcp12639-cit-0026","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1517\/14728214.2014.879291","article-title":"Current and emerging drug treatments for binge eating disorder","volume":"19","author":"Reas","year":"2014","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1111\/ijcp.12639-BIB0027|ijcp12639-cit-0027","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/TCRM.S25574","article-title":"Pharmacological management of binge eating disorder: current and emerging treatment options","volume":"8","author":"McElroy","year":"2012","journal-title":"Ther Clin Risk Manag"},{"key":"10.1111\/ijcp.12639-BIB0028|ijcp12639-cit-0028","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1038\/oby.2008.333","article-title":"Review and meta-analysis of pharmacotherapy for binge-eating disorder","volume":"16","author":"Reas","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1111\/ijcp.12639-BIB0029|ijcp12639-cit-0029","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/ijcp.12587","article-title":"Lorcaserin, phentermine topiramate combination, and naltrexone bupropion combination for weight loss: the 15-min challenge to sort these agents out","volume":"68","author":"Citrome","year":"2014","journal-title":"Int J Clin Pract"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12639","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T17:19:25Z","timestamp":1717780765000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,6]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.12639","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3,6]]},"assertion":[{"value":"2014-10-14","name":"published_online","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}